JP2000511888A5 - - Google Patents

Download PDF

Info

Publication number
JP2000511888A5
JP2000511888A5 JP1997540229A JP54022997A JP2000511888A5 JP 2000511888 A5 JP2000511888 A5 JP 2000511888A5 JP 1997540229 A JP1997540229 A JP 1997540229A JP 54022997 A JP54022997 A JP 54022997A JP 2000511888 A5 JP2000511888 A5 JP 2000511888A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997540229A
Other languages
English (en)
Other versions
JP2000511888A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/007874 external-priority patent/WO1997041863A1/en
Publication of JP2000511888A publication Critical patent/JP2000511888A/ja
Publication of JP2000511888A5 publication Critical patent/JP2000511888A5/ja
Ceased legal-status Critical Current

Links

Description

Figure 2000511888
Figure 2000511888
JP09540229A 1996-05-09 1997-05-08 混合キメリズム及び寛容 Ceased JP2000511888A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1709996P 1996-05-09 1996-05-09
US60/017,099 1996-05-09
PCT/US1997/007874 WO1997041863A1 (en) 1996-05-09 1997-05-08 Mixed chimerism and tolerance

Publications (2)

Publication Number Publication Date
JP2000511888A JP2000511888A (ja) 2000-09-12
JP2000511888A5 true JP2000511888A5 (ja) 2005-01-13

Family

ID=21780711

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09540229A Ceased JP2000511888A (ja) 1996-05-09 1997-05-08 混合キメリズム及び寛容

Country Status (9)

Country Link
US (4) US6006752A (ja)
EP (1) EP0918524A4 (ja)
JP (1) JP2000511888A (ja)
AT (1) ATE245990T1 (ja)
AU (1) AU734665B2 (ja)
CA (1) CA2253597A1 (ja)
DE (1) DE69723888T2 (ja)
ES (1) ES2201977T3 (ja)
WO (1) WO1997041863A1 (ja)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871728A (en) 1995-03-31 1999-02-16 University Of Pittsburgh Method of regulating dendritic cell maturation
EP0918524A4 (en) * 1996-05-09 2000-11-08 Gen Hospital Corp MIXED CHIMERISM AND TOLERANCE
CA2309919A1 (en) 1997-11-14 1999-05-27 The General Hospital Corporation Treatment of hematologic disorders
EP1058555B1 (en) 1998-02-04 2004-04-28 The General Hospital Corporation Costimulatory blockade and mixed chimerism in allotransplantation
AU755888B2 (en) * 1998-03-18 2003-01-02 Mesoblast International Sarl Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
WO2000011147A1 (en) 1998-08-20 2000-03-02 The General Hospital Corporation Inbred mhc-homozygous miniature swine and uses thereof
AU2980900A (en) 1999-02-04 2000-08-25 General Hospital Corporation, The Methods for human allografting
WO2000054786A1 (en) * 1999-03-15 2000-09-21 Modex Therapeutiques, S.A. Methods and compositions for tolerizing hosts for long term survival of tissue transplants
US6750023B2 (en) * 1999-09-02 2004-06-15 Corning Incorporated Porous inorganic substrate for high-density arrays
US20010046489A1 (en) * 1999-12-06 2001-11-29 Habener Joel E. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
JP2003523233A (ja) * 2000-01-19 2003-08-05 バイオトランスプラント,インコーポレイテッド ブタ内因性レトロウイルスの伝達を欠くブタおよびその用途
WO2002044343A2 (en) * 2000-11-22 2002-06-06 Geron Corporation Tolerizing allografts of pluripotent stem cells
US20030044398A1 (en) * 2001-03-20 2003-03-06 Robl James M. Methods for producing antibodies in mammals
WO2002074938A1 (en) * 2001-03-20 2002-09-26 Trustees Of Amherst College Methods for producing antibodies in mammals
US20020152490A1 (en) * 2001-04-12 2002-10-17 Philip Lake Tolerance-inducing thy-marrow composite tissue construct and organ
US20030031652A1 (en) * 2001-04-16 2003-02-13 Bernhard Hering Systems and methods for inducing mixed chimerism
US20030032631A1 (en) * 2001-08-13 2003-02-13 Mcdonald George B. Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods
AU2003228768B2 (en) * 2002-05-22 2009-02-05 The Cleveland Clinic Foundation Induction and maintenance of tolerance to composite tissue allografts
US20050058641A1 (en) * 2002-05-22 2005-03-17 Siemionow Maria Z. Tolerance induction and maintenance in hematopoietic stem cell allografts
US20050112122A1 (en) * 2003-09-02 2005-05-26 Greiner Dale L. Generation of hematopoietic chimerism and induction of central tolerance
US20050266001A1 (en) * 2004-04-02 2005-12-01 Hadley Gregg A Therapeutic blockade of CD103 interactions to prevent clinical renal allograft rejection
US20060147429A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Facilitated cellular reconstitution of organs and tissues
US20060148080A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Methods for supporting and producing human cells and tissues in non-human mammal hosts
US20070113297A1 (en) * 2005-09-13 2007-05-17 Yongguang Yang Methods and compositions for inhibition of immune responses
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
EP2155860B1 (en) 2007-05-03 2014-08-27 The Brigham and Women's Hospital, Inc. Multipotent stem cells and uses thereof
US8574567B2 (en) * 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
GB2526228B (en) 2013-02-26 2017-05-03 Univ Leland Stanford Junior Combined organ and hematopoietic cells for transplantation tolerance of grafts
AU2014248090B2 (en) 2013-04-03 2018-08-02 N-Fold Llc Novel nanoparticle compositions
GB201413240D0 (en) * 2014-07-25 2014-09-10 Hansa Medical Ab Method
WO2019178106A1 (en) 2018-03-12 2019-09-19 Medeor Therapeutics, Inc. Methods for treating non-cancerous disorders using hematopoietic cells
US10842821B2 (en) 2018-04-05 2020-11-24 Medeor Therapeutics, Inc. Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
US10881692B2 (en) 2018-04-05 2021-01-05 Medeor Therapeutics, Inc. Compositions for establishing mixed chimerism and methods of manufacture thereof
US11435350B2 (en) 2018-09-18 2022-09-06 Medeor Therapeutics, Inc. Methods of analysis of blood from deceased donors
US11813376B2 (en) 2018-09-18 2023-11-14 Medeor Therapeutics, Inc. Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2126094A1 (en) * 1992-01-08 1993-07-22 David H. Sachs Induced tolerence to xenografts
US5658564A (en) * 1992-02-19 1997-08-19 The General Hospital Corporation Xenograft thymus
US5876708A (en) * 1992-02-19 1999-03-02 The General Hospital Corporation Allogeneic and xenogeneic transplantation
US5597563A (en) * 1992-09-04 1997-01-28 Beschorner; William E. Method induction of antigen-specific immune tolerance
IL107483A0 (en) * 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
EP0918524A4 (en) 1996-05-09 2000-11-08 Gen Hospital Corp MIXED CHIMERISM AND TOLERANCE
EP1058555B1 (en) * 1998-02-04 2004-04-28 The General Hospital Corporation Costimulatory blockade and mixed chimerism in allotransplantation

Similar Documents

Publication Publication Date Title
JP2000502280A5 (ja)
JP2000501771A5 (ja)
JP2000501599A5 (ja)
JP2000501018A5 (ja)
JP2000505452A5 (ja)
JP2000501324A5 (ja)
JP2000502472A5 (ja)
JP2000501338A5 (ja)
JP2000501825A5 (ja)
JP2000500874A5 (ja)
JP2000515570A5 (ja)
JP2000502485A5 (ja)
JP2000501774A5 (ja)
JP2000502425A5 (ja)
JP2000502570A5 (ja)
JP2000502568A5 (ja)
JP2000500912A5 (ja)
JP2000501876A5 (ja)
JP2000511888A5 (ja)
JP2000514140A5 (ja)
JP2000501744A5 (ja)
JP2000502316A5 (ja)
JP2000502714A5 (ja)
JP2000501229A5 (ja)
JP2000514419A5 (ja)